190 related articles for article (PubMed ID: 25119600)
1. TES was epigenetically silenced and suppressed the epithelial-mesenchymal transition in breast cancer.
Yongbin Y; Jinghua L; Zhanxue Z; Aimin Z; Youchao J; Yanhong S; Manjing J
Tumour Biol; 2014 Nov; 35(11):11381-9. PubMed ID: 25119600
[TBL] [Abstract][Full Text] [Related]
2. TESTIN was commonly hypermethylated and involved in the epithelial-mesenchymal transition of endometrial cancer.
Dong R; Pu H; Wang Y; Yu J; Lian K; Mao C
APMIS; 2015 May; 123(5):394-400. PubMed ID: 25720371
[TBL] [Abstract][Full Text] [Related]
3. Comparative gene expression analysis between coronary arteries and internal mammary arteries identifies a role for the TES gene in endothelial cell functions relevant to coronary artery disease.
Archacki SR; Angheloiu G; Moravec CS; Liu H; Topol EJ; Wang QK
Hum Mol Genet; 2012 Mar; 21(6):1364-73. PubMed ID: 22156939
[TBL] [Abstract][Full Text] [Related]
4. Testin is a tumor suppressor and prognostic marker in breast cancer.
Zhu J; Li X; Kong X; Moran MS; Su P; Haffty BG; Yang Q
Cancer Sci; 2012 Dec; 103(12):2092-101. PubMed ID: 22957844
[TBL] [Abstract][Full Text] [Related]
5. Hic-5 promotes invadopodia formation and invasion during TGF-β-induced epithelial-mesenchymal transition.
Pignatelli J; Tumbarello DA; Schmidt RP; Turner CE
J Cell Biol; 2012 Apr; 197(3):421-37. PubMed ID: 22529104
[TBL] [Abstract][Full Text] [Related]
6. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
Lin D; Kuang G; Wan J; Zhang X; Li H; Gong X; Li H
Oncol Rep; 2017 Feb; 37(2):895-902. PubMed ID: 27959422
[TBL] [Abstract][Full Text] [Related]
7. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
8. NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer.
Kong C; Wang C; Wang L; Ma M; Niu C; Sun X; Du J; Dong Z; Zhu S; Lu J; Huang B
PLoS One; 2011; 6(7):e22666. PubMed ID: 21829474
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
[TBL] [Abstract][Full Text] [Related]
10. TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis.
Wang DD; Chen YB; Zhao JJ; Zhang XF; Zhu GC; Weng DS; Pan K; Lv L; Pan QZ; Jiang SS; Wang LL; Xia JC
Cancer Commun (Lond); 2019 Feb; 39(1):3. PubMed ID: 30728082
[TBL] [Abstract][Full Text] [Related]
11. A complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells.
Ngan E; Northey JJ; Brown CM; Ursini-Siegel J; Siegel PM
J Cell Sci; 2013 May; 126(Pt 9):1981-91. PubMed ID: 23447672
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
Wang J; Liang S; Duan X
J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
[TBL] [Abstract][Full Text] [Related]
13. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
[TBL] [Abstract][Full Text] [Related]
15. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R
Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676
[TBL] [Abstract][Full Text] [Related]
16. Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction.
Yue X; Zhao Y; Zhang C; Li J; Liu Z; Liu J; Hu W
Oncotarget; 2016 Jan; 7(4):3777-90. PubMed ID: 26716902
[TBL] [Abstract][Full Text] [Related]
17. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits LPS-induced EMT through downregulation of NF-κB-Snail signaling in breast cancer cells.
Huang T; Chen Z; Fang L
Oncol Rep; 2013 Jan; 29(1):117-24. PubMed ID: 23076367
[TBL] [Abstract][Full Text] [Related]
19. LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.
Yang F; Zhou X; Du S; Zhao Y; Ren W; Deng Q; Wang F; Yuan J
PLoS One; 2014; 9(6):e100557. PubMed ID: 24955835
[TBL] [Abstract][Full Text] [Related]
20. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
